Exagen results for the quarter ended September 30, 2026, are scheduled for release before the market opens on November 10. The autoimmune diagnostics company announced the date on October 27 without disclosing the financial figures.

Exagen results webcast

President and Chief Executive Officer John Aballi and Chief Financial Officer Jeff Black will host a webcast to review the results at 8:00 a.m. ET, or 5:00 a.m. PT, on November 10.

The webcast will be available through Exagen’s investor relations website. Participants who want to join by phone must register in advance to receive dial-in instructions. A webcast replay will remain available on the investor relations site for 12 months.

About the diagnostics company

Exagen, based in California’s San Diego County, provides autoimmune testing. Its flagship AVISE CTD test is designed to help diagnose complex autoimmune conditions, including lupus, rheumatoid arthritis and Sjögren’s disease.

The company’s shares trade on Nasdaq under the ticker XGN.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.